NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT
FIELD: organic chemistry, medicine, oncology, pharmacy. ^ SUBSTANCE: invention relates to nonhygroscopic crystalline 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,2-dimethyl-1H-pyrrol-3-carboxamide maleate salt that possesses inhibitory eff...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SONG DONG LU TSJUN MOREJDZHIS MAJKL EHNTONI TSZIN' TSINVU BLASKO ANDREJ VONDERVELL BRENDA S'JU |
description | FIELD: organic chemistry, medicine, oncology, pharmacy. ^ SUBSTANCE: invention relates to nonhygroscopic crystalline 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,2-dimethyl-1H-pyrrol-3-carboxamide maleate salt that possesses inhibitory effect on tyrosine kinase receptors. Also, invention relates to a pharmaceutical composition and to a method for treatment of cancer in mammals using such compositions. ^ EFFECT: valuable medicinal property of compound and pharmaceutical composition. ^ 12 cl, 12 tbl, 17 dwg, 5 ex |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2319702C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2319702C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2319702C23</originalsourceid><addsrcrecordid>eNqNjMFKAzEURWfjQtR_eMsO9IGTaRGXMcmYQJIX3mRgokgpMq5EC_XD_QTT6ge4unA551w235GiLY9Mo6LkFCguY5beu2hgi8-rpxZXWxz8REwokGbCbi1QO1t0fXqLLmry2GPxTpto2mCyLf4FY7XF2FbpjM6lMoE4Wapx3FQ-MaUTKdabGvz1sLOYCvM5qSQ_0CxDDUOQ3shsYJQ-ryFZyUEqM2WnpAdFIdHosqMIMmo4tUjDQAxKRmUYMlc7mJivm4u3_ftxufnbqwYGk5XF5fC5W46H_evysXzteBJ9d393K5To_4H8APY-Wbw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT</title><source>esp@cenet</source><creator>SONG DONG ; LU TSJUN ; MOREJDZHIS MAJKL EHNTONI ; TSZIN' TSINVU ; BLASKO ANDREJ ; VONDERVELL BRENDA S'JU</creator><creatorcontrib>SONG DONG ; LU TSJUN ; MOREJDZHIS MAJKL EHNTONI ; TSZIN' TSINVU ; BLASKO ANDREJ ; VONDERVELL BRENDA S'JU</creatorcontrib><description>FIELD: organic chemistry, medicine, oncology, pharmacy. ^ SUBSTANCE: invention relates to nonhygroscopic crystalline 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,2-dimethyl-1H-pyrrol-3-carboxamide maleate salt that possesses inhibitory effect on tyrosine kinase receptors. Also, invention relates to a pharmaceutical composition and to a method for treatment of cancer in mammals using such compositions. ^ EFFECT: valuable medicinal property of compound and pharmaceutical composition. ^ 12 cl, 12 tbl, 17 dwg, 5 ex</description><language>eng ; rus</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080320&DB=EPODOC&CC=RU&NR=2319702C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080320&DB=EPODOC&CC=RU&NR=2319702C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SONG DONG</creatorcontrib><creatorcontrib>LU TSJUN</creatorcontrib><creatorcontrib>MOREJDZHIS MAJKL EHNTONI</creatorcontrib><creatorcontrib>TSZIN' TSINVU</creatorcontrib><creatorcontrib>BLASKO ANDREJ</creatorcontrib><creatorcontrib>VONDERVELL BRENDA S'JU</creatorcontrib><title>NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT</title><description>FIELD: organic chemistry, medicine, oncology, pharmacy. ^ SUBSTANCE: invention relates to nonhygroscopic crystalline 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,2-dimethyl-1H-pyrrol-3-carboxamide maleate salt that possesses inhibitory effect on tyrosine kinase receptors. Also, invention relates to a pharmaceutical composition and to a method for treatment of cancer in mammals using such compositions. ^ EFFECT: valuable medicinal property of compound and pharmaceutical composition. ^ 12 cl, 12 tbl, 17 dwg, 5 ex</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjMFKAzEURWfjQtR_eMsO9IGTaRGXMcmYQJIX3mRgokgpMq5EC_XD_QTT6ge4unA551w235GiLY9Mo6LkFCguY5beu2hgi8-rpxZXWxz8REwokGbCbi1QO1t0fXqLLmry2GPxTpto2mCyLf4FY7XF2FbpjM6lMoE4Wapx3FQ-MaUTKdabGvz1sLOYCvM5qSQ_0CxDDUOQ3shsYJQ-ryFZyUEqM2WnpAdFIdHosqMIMmo4tUjDQAxKRmUYMlc7mJivm4u3_ftxufnbqwYGk5XF5fC5W46H_evysXzteBJ9d393K5To_4H8APY-Wbw</recordid><startdate>20080320</startdate><enddate>20080320</enddate><creator>SONG DONG</creator><creator>LU TSJUN</creator><creator>MOREJDZHIS MAJKL EHNTONI</creator><creator>TSZIN' TSINVU</creator><creator>BLASKO ANDREJ</creator><creator>VONDERVELL BRENDA S'JU</creator><scope>EVB</scope></search><sort><creationdate>20080320</creationdate><title>NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT</title><author>SONG DONG ; LU TSJUN ; MOREJDZHIS MAJKL EHNTONI ; TSZIN' TSINVU ; BLASKO ANDREJ ; VONDERVELL BRENDA S'JU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2319702C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2008</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SONG DONG</creatorcontrib><creatorcontrib>LU TSJUN</creatorcontrib><creatorcontrib>MOREJDZHIS MAJKL EHNTONI</creatorcontrib><creatorcontrib>TSZIN' TSINVU</creatorcontrib><creatorcontrib>BLASKO ANDREJ</creatorcontrib><creatorcontrib>VONDERVELL BRENDA S'JU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SONG DONG</au><au>LU TSJUN</au><au>MOREJDZHIS MAJKL EHNTONI</au><au>TSZIN' TSINVU</au><au>BLASKO ANDREJ</au><au>VONDERVELL BRENDA S'JU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT</title><date>2008-03-20</date><risdate>2008</risdate><abstract>FIELD: organic chemistry, medicine, oncology, pharmacy. ^ SUBSTANCE: invention relates to nonhygroscopic crystalline 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,2-dimethyl-1H-pyrrol-3-carboxamide maleate salt that possesses inhibitory effect on tyrosine kinase receptors. Also, invention relates to a pharmaceutical composition and to a method for treatment of cancer in mammals using such compositions. ^ EFFECT: valuable medicinal property of compound and pharmaceutical composition. ^ 12 cl, 12 tbl, 17 dwg, 5 ex</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; rus |
recordid | cdi_epo_espacenet_RU2319702C2 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T08%3A58%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SONG%20DONG&rft.date=2008-03-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2319702C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |